Skip to main content
. Author manuscript; available in PMC: 2013 Oct 19.
Published in final edited form as: Pharm Res. 2009 Mar 17;26(6):1516–1524. doi: 10.1007/s11095-009-9864-8

Fig. 6.

Fig. 6

Immunomodulatory effects of ODN and ODN nanoparticles in tumor-bearing nude mice. a Induction of IL-12 expression. For the study, 6–8 week old nude mice bearing K562 tumor were untreated or given 5 mg/kg of various ODN formulations by tail vein injection. IL-12 levels were measured by ELISA, as described in the “MATERIALS AND METHODs” section. b Spleen weights for nude mice (n=5) that were untreated or treated with various ODN formulations or empty liposomes (Tf-LP).